FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2174745761> ?p ?o ?g. }

• W2174745761 endingPage "44562" @default.
• W2174745761 startingPage "44551" @default.
• W2174745761 abstract "Ovarian cancer is the most common cause of death among women with gynecologic cancer. We examined molecular profiles of fibroblasts from normal ovary and high-grade serous ovarian tumors to identify novel therapeutic targets involved in tumor progression. We identified 2,300 genes that are significantly differentially expressed in tumor-associated fibroblasts. Fibroblast expression of one of these genes, connective tissue growth factor (CTGF), was confirmed by immunohistochemistry. CTGF protein expression in ovarian tumor fibroblasts significantly correlated with gene expression levels. CTGF is a secreted component of the tumor microenvironment and is being pursued as a therapeutic target in pancreatic cancer. We examined its effect in in vitro and ex vivo ovarian cancer models, and examined associations between CTGF expression and clinico-pathologic characteristics in patients. CTGF promotes migration and peritoneal adhesion of ovarian cancer cells. These effects are abrogated by FG-3019, a human monoclonal antibody against CTGF, currently under clinical investigation as a therapeutic agent. Immunohistochemical analyses of high-grade serous ovarian tumors reveal that the highest level of tumor stromal CTGF expression was correlated with the poorest prognosis. Our findings identify CTGF as a promoter of peritoneal adhesion, likely to mediate metastasis, and a potential therapeutic target in high-grade serous ovarian cancer. These results warrant further studies into the therapeutic efficacy of FG-3019 in high-grade serous ovarian cancer." @default.
• W2174745761 created "2016-06-24" @default.
• W2174745761 creator A5008006004 @default.
• W2174745761 creator A5009039019 @default.
• W2174745761 creator A5010693778 @default.
• W2174745761 creator A5012694789 @default.
• W2174745761 creator A5018860994 @default.
• W2174745761 creator A5025903474 @default.
• W2174745761 creator A5030277742 @default.
• W2174745761 creator A5055296814 @default.
• W2174745761 creator A5055849515 @default.
• W2174745761 creator A5056675811 @default.
• W2174745761 creator A5058094849 @default.
• W2174745761 creator A5063657901 @default.
• W2174745761 creator A5064419411 @default.
• W2174745761 creator A5072808685 @default.
• W2174745761 creator A5081561534 @default.
• W2174745761 creator A5086428743 @default.
• W2174745761 creator A5089482204 @default.
• W2174745761 date "2015-11-11" @default.
• W2174745761 modified "2023-10-17" @default.
• W2174745761 title "Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer" @default.
• W2174745761 cites W1500749800 @default.
• W2174745761 cites W1656339735 @default.
• W2174745761 cites W1961928411 @default.
• W2174745761 cites W1965891567 @default.
• W2174745761 cites W1966501740 @default.
• W2174745761 cites W1968535565 @default.
• W2174745761 cites W1974926454 @default.
• W2174745761 cites W1978352189 @default.
• W2174745761 cites W1990719188 @default.
• W2174745761 cites W1992035698 @default.
• W2174745761 cites W1993450230 @default.
• W2174745761 cites W1998258610 @default.
• W2174745761 cites W2004144597 @default.
• W2174745761 cites W2017448826 @default.
• W2174745761 cites W2051919050 @default.
• W2174745761 cites W2053263835 @default.
• W2174745761 cites W2053865773 @default.
• W2174745761 cites W2075823443 @default.
• W2174745761 cites W2078354424 @default.
• W2174745761 cites W2085000900 @default.
• W2174745761 cites W2092240515 @default.
• W2174745761 cites W2098749998 @default.
• W2174745761 cites W2099704453 @default.
• W2174745761 cites W2101242266 @default.
• W2174745761 cites W2106074488 @default.
• W2174745761 cites W2112475965 @default.
• W2174745761 cites W2113317460 @default.
• W2174745761 cites W2114752142 @default.
• W2174745761 cites W2115596977 @default.
• W2174745761 cites W2115657997 @default.
• W2174745761 cites W2122742138 @default.
• W2174745761 cites W2123696077 @default.
• W2174745761 cites W2127724027 @default.
• W2174745761 cites W2131593373 @default.
• W2174745761 cites W2136662615 @default.
• W2174745761 cites W2138202356 @default.
• W2174745761 cites W2143647993 @default.
• W2174745761 cites W2146350838 @default.
• W2174745761 cites W2148673949 @default.
• W2174745761 cites W2149473539 @default.
• W2174745761 cites W2152266202 @default.
• W2174745761 cites W2161817637 @default.
• W2174745761 cites W2162424291 @default.
• W2174745761 cites W2167526069 @default.
• W2174745761 cites W2322628265 @default.
• W2174745761 cites W2328421677 @default.
• W2174745761 doi "https://doi.org/10.18632/oncotarget.6082" @default.
• W2174745761 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4792575" @default.
• W2174745761 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26575166" @default.
• W2174745761 hasPublicationYear "2015" @default.
• W2174745761 type Work @default.
• W2174745761 sameAs 2174745761 @default.
• W2174745761 citedByCount "34" @default.
• W2174745761 countsByYear W21747457612016 @default.
• W2174745761 countsByYear W21747457612017 @default.
• W2174745761 countsByYear W21747457612018 @default.
• W2174745761 countsByYear W21747457612019 @default.
• W2174745761 countsByYear W21747457612020 @default.
• W2174745761 countsByYear W21747457612021 @default.
• W2174745761 countsByYear W21747457612022 @default.
• W2174745761 countsByYear W21747457612023 @default.
• W2174745761 crossrefType "journal-article" @default.
• W2174745761 hasAuthorship W2174745761A5008006004 @default.
• W2174745761 hasAuthorship W2174745761A5009039019 @default.
• W2174745761 hasAuthorship W2174745761A5010693778 @default.
• W2174745761 hasAuthorship W2174745761A5012694789 @default.
• W2174745761 hasAuthorship W2174745761A5018860994 @default.
• W2174745761 hasAuthorship W2174745761A5025903474 @default.
• W2174745761 hasAuthorship W2174745761A5030277742 @default.
• W2174745761 hasAuthorship W2174745761A5055296814 @default.
• W2174745761 hasAuthorship W2174745761A5055849515 @default.
• W2174745761 hasAuthorship W2174745761A5056675811 @default.
• W2174745761 hasAuthorship W2174745761A5058094849 @default.
• W2174745761 hasAuthorship W2174745761A5063657901 @default.
• W2174745761 hasAuthorship W2174745761A5064419411 @default.
• W2174745761 hasAuthorship W2174745761A5072808685 @default.

• next